Holen Sie sich die Stockscreener-App
0.4102
1.87%
-0.0078
Schlusskurs vom Vortag:
$0.418
Offen:
$0.4179
24-Stunden-Volumen:
323.54K
Relative Volume:
0.11
Marktkapitalisierung:
$16.67M
Einnahmen:
$653.40K
Nettoeinkommen (Verlust:
$-20.19M
KGV:
-0.2267
EPS:
-1.8091
Netto-Cashflow:
$-11.11M
1W Leistung:
+3.85%
1M Leistung:
-10.85%
6M Leistung:
-73.87%
1J Leistung:
-56.82%
1-Tages-Spanne:
$0.4052
$0.4248
1-Wochen-Bereich:
$0.37
$0.44
52-Wochen-Spanne:
$0.2382
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
Firmenname
Scienture Holdings Inc
Sektor
Branche
Telefon
(800) 261 0281
Adresse
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, POM, WGRX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.4102 | 16.98M | 653.40K | -20.19M | -11.11M | -1.8091 |
HITI
High Tide Inc
|
2.47 | 210.95M | 452.61M | -35.30M | 13.25M | -0.3863 |
PETS
Petmed Express Inc
|
2.29 | 47.72M | 182.67M | -64.87M | -22.92M | -3.1193 |
POM
Pomdoctor Ltd Adr
|
0.3928 | 47.30M | 0 | 0 | 0 | 0.00 |
WGRX
Wellgistics Health Inc
|
0.1298 | 17.19M | 23.34M | -101.27M | -11.74M | -1.2919 |
Scienture Holdings Inc Aktie (SCNX) Neueste Nachrichten
Scienture Holdings files to sell 2.1M shares for holders - MSN
Scienture files $200M mixed securities shelf - MSN
Scienture granted 180-day extension by Nasdaq to regain compliance - MSN
Scienture Holdings (SCNX) Stock: What Affects Its Direction | Q4 2025: Profit Exceeds ViewsPopular Trader Picks - Cổng thông tin điện tử tỉnh Lào Cai
Scienture Holdings (SCNX) Stock: Stability Assessment (Spikes) 2026-04-20Support Bounce - Cổng thông tin điện tử Tỉnh Sơn La
SCNX | Scienture Holdings, Inc. Common Insider Trading - Quiver Quantitative
Scienture (SCNX) Receives Nasdaq Extension for Compliance - GuruFocus
Scienture receives Nasdaq extension to regain compliance By Investing.com - Investing.com Canada
Scienture Holdings, Inc. Receives Additional 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Quiver Quantitative
Scienture receives Nasdaq extension to regain compliance - Investing.com
Scienture Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - The Globe and Mail
Aug Decliners: Is Scienture Holdings Inc gaining market share2026 Macro Impact & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Dividend Watch: Is Scienture Holdings Inc stock a good pick for beginners2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Market Pulse: Is LEXXW forming bullish engulfing patternsTake Profit & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Is Scienture Holdings (SCNX) Stock a Buy or Sell | Price at $0.34, Up 4.43%Vega Volatility - Xã Châu Thành
Market Recap: What is Scienture Holdings Incs debt to equity ratioRate Cut & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
What accelerates growth of Scienture Holdings (SCNX) Stock | Price at $0.32, Down 1.13%Real-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Scienture posts 216% revenue growth, plans second product launch By Investing.com - Investing.com Australia
Scienture posts 216% revenue growth, plans second product launch - Investing.com
Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead - The Manila Times
Exclusive: Penny stock Scienture reports revenue surge, expanding market access in 2025 - MSN
SCNX PE Ratio & Valuation, Is SCNX Overvalued - Intellectia AI
SCNX Stock Analysis: Scienture Holdings Inc. 0.29 price with 2.81 pct daily gain - Cổng thông tin điện tử tỉnh Tây Ninh
Scienture reports 216% revenue growth, gross margin expansion By Investing.com - Investing.com Australia
Scienture Holdings Inc (MEDS) Reports FY2025 Earnings - AlphaStreet
Tempest Therapeutics, Inc. (TPST) Reports FY2025 Earnings - AlphaStreet
Scienture Holdings, Inc. 2025 Annual Report: Key Risks, Forward-Looking Statements, and Business Overview - Minichart
Scienture Holdings: Q4 Earnings Snapshot - marketscreener.com
Scienture reports 216% revenue growth, gross margin expansion - Investing.com
SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update - The Globe and Mail
Scienture Holdings 10-K: $0.43M Revenue, $(2.70) EPS — ARBLI™ Launch Drives Growth - TradingView — Track All Markets
Scienture’s blood pressure drug drove 216% growth; overdose spray up next - Stock Titan
Scienture Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Scienture Holdings (NASDAQ: SCNX) outlines CNS, CVS drug launches and pipeline - Stock Titan
EXCLUSIVE: Penny Stock Scienture Reports Revenue Surge, Expanding Market Access In 2025 - Benzinga
Scienture Holdings Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Aug Decliners: Will Scienture Holdings Inc be affected by tariffsAnalyst Downgrade & Verified Entry Point Signals - baoquankhu1.vn
If You Invested $1,000 in Scienture Holdings, Inc (SCNX) - Stock Titan
Gap Down: What are analysts price targets for Scienture Holdings Inc2026 Technical Overview & Expert Approved Trade Ideas - baoquankhu1.vn
Finanzdaten der Scienture Holdings Inc-Aktie (SCNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.32%
3.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):